Has Tracy Dilley received payments from drug or device companies?

Yes. Drug and device makers reported $3,723 in general payments to Tracy Dilley across 149 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tracy Dilley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tracy Dilley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tracy Dilley

Family · Fort Worth, TXNPI 1215589726

Payments from drug & device makers

$3,723in general payments, 2019–2025

Across 149 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$556
Actelion Pharmaceuticals US, Inc.$476
Novartis$457
E.r. Squibb & Sons, L.L.C.$361
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$279
Pfizer$276
plus $1K from 16 others

What the payments were for

Food & beverage$3,67099%
Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	8	$556
Actelion Pharmaceuticals US, Inc.	13	$476
Novartis	25	$457
E.r. Squibb & Sons, L.L.C.	13	$361
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	10	$279
Pfizer	18	$276
Boehringer Ingelheim	10	$242
Sanofi-aventis U.S. LLC	13	$228
AstraZeneca	6	$214
Alnylam Pharmaceuticals Inc.	7	$147
Merck	7	$125
Amgen	5	$85
Abiomed	1	$51
Johnson & Johnson	4	$46
Edwards Lifesciences	1	$35
Boston Scientific	1	$32
Amarin Pharma, Inc.	2	$31
Lantheus Medical Imaging, Inc.	1	$18
Novo Nordisk	1	$18
Biotronik Inc.	1	$17
Astellas Pharma US Inc	1	$16
Saranas, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,723 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	296	$268,209
JardianceEmpagliflozin	95	$85,060
EntrestoSacubitril/Valsartan	83	$81,936
XareltoRivaroxaban	39	$41,804
BrilintaTicagrelor	58	$39,013
Repatha SureclickEvolocumab	43	$33,963
Ranolazine ErRanolazine	103	$6,515
Rosuvastatin Calcium	242	$3,617
ClopidogrelClopidogrel Bisulfate	208	$2,970
Atorvastatin Calcium	238	$2,436
Metoprolol Succinate	202	$2,248
Prasugrel Hcl	25	$2,011
Ezetimibe	74	$1,573
Carvedilol	146	$1,563
Amlodipine Besylate	183	$1,524

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$276	$268,209296 claims
Boehringer IngelheimJardiance	$242	$85,06095 claims
NovartisEntresto	$457	$81,93683 claims
Johnson & JohnsonXarelto	$46	$41,80439 claims
AstraZenecaBrilinta	$214	$39,01358 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.

Other family in Fort Worth

Laura MoeFort Worth$158K
Julie TaylorFort Worth$63K
Ryan BourgeoisFort Worth$37K
Lashonda CraneHouston$3.4M
David WeirDallas$959K
Luba YammineHouston$479K
Robin BeachHouston$428K
Nirupama JeromeAustin$418K
April LopezMcAllen$417K
Linda MercadoHouston$211K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →